Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells

Endocrinology
J K RuoholaP L Härkönen

Abstract

We studied the androgen regulation of fibroblast growth factor (FGF) receptors (FGFRs) in the Shionogi 115 (S115) mouse mammary tumor cell line and its genetic variant Clone 22. In S115 cells, androgen maintains a transformed morphology, rate of proliferation, and serum and anchorage independence. Similar effects were induced by treatment of the cells with FGF-2 or a heparin-binding growth factor (HBGF) fraction prepared from the medium conditioned by the cells. The effects of androgen and FGF-2 could be partly reversed with a specific anti-FGF-2 immunoglobulin G or by suramin, which inhibits binding of FGFs to their high affinity receptors. Testosterone and FGF-2 increased the expression of FGFR-1 messenger RNA (mRNA) and, to a lesser extent, FGFR-3 mRNA, but down-regulated FGFR-2 mRNA in S115 cells. No FGFR-4 mRNA was detected. FGF-2 also down-regulated the expression of syndecan-1, a heparan sulfate proteoglycan that binds FGF with low affinity. The binding of radiolabeled FGF-2 to FGFRs was lower in the cells cultured with testosterone or in the presence of the HBGFs from androgen-treated cells, presumably because of the autocrine production of FGF-like factors. In Clone 22 cells, FGFRs and syndecan-1 responded to androgen ...Continue Reading

Citations

Jul 1, 1997·Brain Research. Molecular Brain Research·Y HattoriN Itoh
May 13, 2008·Pathology Oncology Research : POR·L KopperI Kovalszky
May 6, 2009·Journal of Cellular Biochemistry·Maija P ValtaPirkko L Härkönen
May 26, 2006·Molecular and Cellular Endocrinology·Mirjami M MattilaPirkko L Härkönen
Nov 16, 2004·Biochemical and Biophysical Research Communications·Matti J SirénPirkko Härkönen
Mar 23, 2001·Experimental Cell Research·M BorgenströmM Jalkanen
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Pei-San Tsai, John C Gill
Oct 28, 2005·Genes, Chromosomes & Cancer·Anat Erdreich-EpsteinGregory M Shackleford
Jan 28, 2006·Endocrinology·Maija P ValtaPirkko L Härkönen
May 15, 2003·American Journal of Physiology. Endocrinology and Metabolism·Helen C CocksMargaret C Eggo
Sep 30, 2003·The Journal of Biological Chemistry·Marjut BorgenströmMarkku Salmivirta
Jun 22, 2002·The Journal of Biological Chemistry·Britt-Marie Loo, Markku Salmivirta
Oct 24, 1998·Biochemical and Biophysical Research Communications·E M ValveP L Härkönen
Mar 6, 1997·Biochemical and Biophysical Research Communications·E ValveP Härkönen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.